No Photo Available

Last Update


This profile was last updated on .

Is this you? Claim your profile.

Wrong David Weinreich?

Dr. David M. Weinreich MD MBA

Senior Vice President, Late Stage Clinical Development and Medical Affairs

Regeneron Pharmaceuticals , Inc.

Direct Phone: (914) ***-****       

Email: d***@***.com

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Regeneron Pharmaceuticals , Inc.

777 Old Saw Mill River Road

Tarrytown, New York 10591

United States

Company Description

Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases ... more

Find other employees at this company (4,768)

Background Information

Employment History

Columbia University

Senior Vice President, Head Global Development Specialty Medicine

Bayer AG



Web References (5 Total References)

Regeneron Pharmaceuticals, Inc.: Founders [cached]

David Weinreich, M.D. Board of Directors

Regeneron Pharmaceuticals, Inc.: Founders [cached]

David Weinreich, M.D. Board of Directors

"Bayer's oncology pipeline has ... [cached]

"Bayer's oncology pipeline has grown tremendously over the last years", said David Weinreich, Head of Global Clinical Development Oncology at Bayer HealthCare.

Dr. David Weinreich, Head of ... [cached]

Dr. David Weinreich, Head of Therapeutic Area Oncology, Ophthalmology & Neurology, Bayer

"We want to be a major ... [cached]

"We want to be a major oncology player," said David Weinreich, who oversees development of Bayer's cancer drugs.

"We are currently exploring radiation as useful in generating that initial immune response," Weinreich said.
"We are willing to make those investments and hopefully they will pay off in the next 10 to 15 years," Weinreich said.

Similar Profiles

Other People with this Name

Other people with the name Weinreich

Trine Weinreich
Nilfisk-Advance Inc

David Weinreich

Grace Weinreich
Capella University

Anastasia Weinreich
Federal Home Loan Bank of Indianapolis

Jonathan Weinreich
Enzo Life Sciences Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory